Literature DB >> 9486401

Expression of Pax5 gene in human haematopoietic cells and tissues: comparison with immunodeficient donors.

H Kaneko1, T Ariyasu, R Inoue, T Fukao, K Kasahara, T Teramoto, E Matsui, S Hayakawa, N Kondo.   

Abstract

In mice, Pax5 gene is indispensable for B cell development. Pax5-deficient mice fail to produce mature B cells owing to complete arrest of B cell development at a precursor stage. However, the lineage and stage of human Pax5 gene expression have remained elusive. In this investigation expression of the human Pax5 gene was studied. Pax5 gene expression was detected in B cell lines but not in myeloma cell lines. CD19 expression was correlated with Pax5 gene expression. Adult spleen and bone marrow and fetal spleen and liver showed strong Pax5 gene expression, as did the corresponding mouse tissues, as reported previously. In common variable immunodeficiency (CVID) peripheral blood lymphocytes (PBL) with a decreased number of B cells, no Pax5 gene expression was detected. Some CVID PBL stimulated with IL-2, IL-10 and anti-CD40 monoclonal antibody, expressed the Pax5 gene. Defect of Pax5 gene expression in CVID may be caused by regulatory T cell disorder.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486401      PMCID: PMC1904901          DOI: 10.1046/j.1365-2249.1998.00509.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  41 in total

1.  Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.

Authors:  T Han; J Minowada
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

2.  Two E-rosette-forming lymphoid cell lines.

Authors:  S Morikawa; E Tatsumi; M Baba; T Harada; K Yasuhira
Journal:  Int J Cancer       Date:  1978-02-15       Impact factor: 7.396

3.  Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia.

Authors:  H Lazarus; E F Barell; A Krishan; D M Livingston; K Harris; S F Schlossman; L Chess
Journal:  Cancer Res       Date:  1978-05       Impact factor: 12.701

4.  Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients.

Authors:  J M Ferrer; J Iglesias; M Hernández; N Matamoros
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

5.  Monoclonal antibody-toxin conjugates reactive against human T lymphocytes. A comparison of antibody linked to intact ricin toxin with antibody linked to ricin A chain.

Authors:  D A Vallera; R R Quinones; S M Azemove; C C Soderling
Journal:  Transplantation       Date:  1984-04       Impact factor: 4.939

6.  Tumor-associated antigens in human myeloma.

Authors:  R G Krueger; L D Staneck; J M Boehlecke
Journal:  J Natl Cancer Inst       Date:  1976-04       Impact factor: 13.506

7.  Amygdalin (Laetrile): effect on clonogenic cells from human myeloid leukemia cell lines and normal human marrow.

Authors:  H P Koeffler; L Lowe; D W Golde
Journal:  Cancer Treat Rep       Date:  1980-01

8.  Human myeloma cells and their strong stimulating capacity in 'one-way' mixed lymphocyte reaction: a comparative study with leukaemic B lymphoid cells.

Authors:  T Han; B Dadey; J Minowada; D W Golde
Journal:  Immunology       Date:  1979-09       Impact factor: 7.397

9.  Monoclonal antibody SN2 defining a human T cell leukemia-associated cell surface glycoprotein.

Authors:  B K Seon; S Negoro; M P Barcos; C K Tebbi; D Chervinsky; T Fukukawa
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

10.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  6 in total

1.  A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes.

Authors:  Michèle Milili; Laurent Gauthier; Julie Veran; Marie-Geneviève Mattei; Claudine Schiff
Journal:  Immunology       Date:  2002-08       Impact factor: 7.397

2.  Expression of the BLM gene in human haematopoietic cells.

Authors:  H Kaneko; E Matsui; T Fukao; K Kasahara; W Morimoto; N Kondo
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 3.  Overview of PAX gene family: analysis of human tissue-specific variant expression and involvement in human disease.

Authors:  Brian Thompson; Emily A Davidson; Wei Liu; Daniel W Nebert; Elspeth A Bruford; Hongyu Zhao; Emmanouil T Dermitzakis; David C Thompson; Vasilis Vasiliou
Journal:  Hum Genet       Date:  2020-07-29       Impact factor: 4.132

4.  The transcription factor early growth response 1 (Egr-1) advances differentiation of pre-B and immature B cells.

Authors:  A Dinkel; K Warnatz; B Ledermann; A Rolink; P F Zipfel; K Bürki; H Eibel
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

5.  Level of PAX5 in differential diagnosis of non-Hodgkin's lymphoma.

Authors:  Brij Bharti; Sachin Shukla; Ratnakar Tripathi; Suman Mishra; Mohan Kumar; Manoj Pandey; Rajnikant Mishra
Journal:  Indian J Med Res       Date:  2016-05       Impact factor: 2.375

6.  PAX5-Negative Classical Hodgkin Lymphoma: A Case Report of a Rare Entity and Review of the Literature.

Authors:  Elham Vali Betts; Denis M Dwyre; Huan-You Wang; Hooman H Rashidi
Journal:  Case Rep Hematol       Date:  2017-10-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.